Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)

Dr. Thenappan Thenappan

Cardiology | Advanced Heart Failure and Transplant Cardiology
Fairview Express Care
500 Harvard St Se, 
Minneapolis, MN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Fairview Express Care
500 Harvard St Se, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Thenappan Thenappan is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Minneapolis, Minnesota. Dr. Thenappan is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Angioplasty. Dr. Thenappan is currently accepting new patients.

His clinical research consists of co-authoring 123 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles and participated in 3 clinical trials in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Specialties
Cardiology
Advanced Heart Failure and Transplant Cardiology
Licenses
Internal Medicine in MN
Hospital Affiliations
Essentia Health St Mary's Medical Center
M Health Fairview University Of Mn
M Health Fairview Woodwinds Hospital
M Health Fairview Southdale Hospital
M Health Fairview St John's Hospital
Languages Spoken
English
Tamil
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sanford Health
  • HMO
  • PPO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

FAIRVIEW EXPRESS CARE
500 Harvard St Se, Minneapolis, MN 55455
Other Locations
HEALTHEAST MEDICAL RESEARCH INSTITUTE
1700 University Ave W, 6th Floor W, Saint Paul, MN 55104
FAIRVIEW EXPRESS CARE
909 Fulton St Se, Suite 4 392, Minneapolis, MN 55455
FAIRVIEW EXPRESS CARE
717 Delaware St Se, Suite 340, Minneapolis, MN 55414

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
Enrollment Status: Recruiting
Publish Date: September 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Active_not_recruiting
Publish Date: October 03, 2025
Intervention Type: Drug
Study Drug: Sotatercept
Study Phase: Phase 2
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
Beta-blockers in Pulmonary Arterial Hypertension - A Phase 2 Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy, and Safety of Carvedilol for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
Beta-blockers in Pulmonary Arterial Hypertension - A Phase 2 Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy, and Safety of Carvedilol for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

123 Total Publications

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis.
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis.
Journal: American journal of respiratory and critical care medicine
Published: August 07, 2025
Similar Doctors
Elite in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Markus F. Meyer
Cardiology
Elite in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Markus F. Meyer
Cardiology

Fairview Express Care

2450 Riverside Ave, 
Minneapolis, MN 
 (0.4 miles away)
612-672-7422
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients

Markus Meyer is a Cardiologist in Minneapolis, Minnesota. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atrial Fibrillation, and Heart Attack. Dr. Meyer is currently accepting new patients.

Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Rebecca J. Cogswell
Cardiology
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Rebecca J. Cogswell
Cardiology

Fairview Express Care

909 Fulton St Se, Suite 4 392, 
Minneapolis, MN 
 (0.3 miles away)
612-676-4483
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rebecca Cogswell is a Cardiologist in Minneapolis, Minnesota. Dr. Cogswell is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Heart Transplant, and Endoscopy. Dr. Cogswell is currently accepting new patients.

Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Michael A. Samara
Advanced Heart Failure and Transplant Cardiology | Cardiology
Distinguished in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Michael A. Samara
Advanced Heart Failure and Transplant Cardiology | Cardiology

Allina Health System

775 Prairie Ctr Dr, Suite 300, 
Eden Prairie, MN 
 (12.8 miles away)
952-428-0300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Samara is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Eden Prairie, Minnesota. Dr. Samara is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Arrhythmogenic Right Ventricular Cardiomyopathy, Heart Transplant, and Cardiac Ablation. Dr. Samara is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thenappan's expertise for a condition
ConditionClose
View All 30 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile